Eric Newell
Analyst · D.A. Davidson
Thank you, Brad, and good morning. During the quarter, we identified a non-cash goodwill impairment totaling $104.8 million, which resulted in a GAAP loss of $6.01 for the quarter ending September 30th. Driving this impairment is the drop in bank stocks overall, including the company's common stock price, resulting in a lower fair value of our capital versus book value prior to the impairment, the reduction in market multiples of peers used in our valuation analysis, our cash flow forecast in light of uncertainty related to the pandemic and higher discount rates given the environment. The impairment does not affect cash balances, liquidity, tangible book value or regulatory capital ratios. As some of the goodwill was created from taxable events, the effect on capital totaled $99.5 million, with $5.3 million of deferred tax assets being created due to timing differences in expense recognition for book and tax purposes. Let me peel back the GAAP number to assist in understanding core operating performance. Without the goodwill impairment, pre-tax earnings would have been $11.4 million using a pro forma tax rate of 22.5%, the resulting pro forma net income would have been $9.1 million or $0.60 per diluted share. This includes the effect of PPP loans on our balance sheet. During the quarter, we recognized $1.3 million of SBA fees related to PPP loans compared to $1.03 million in the second quarter. Both of these numbers are net of costs associated with originating PPP loans. As a reminder, we will recognize a total net $11 million of fees associated with the PPP program, for which we have already recorded $2.3 million, leaving $8.7 million left to recognize. At September 30th, we had submitted approximately 26% of our PPP dollars for forgiveness and have started to see the SBA forgiving loan balances. We believe that anything that had been submitted by the end of the quarter will be recognized in the fourth quarter this year and the remainder will be recognized in 2021. PPP loans totaled $376 million at September 30th, and the average balance in the quarter totaled $375 million. Interest earned from the PPP loan portfolio was $960,000 during the quarter. Pre-tax pre-provision revenue in the quarter ending September 30th totaled a pro forma $12.6 million when excluding the impairment. This compares to the second quarter pre-tax pre-provision revenue of $14.7 million, which included a non-recurring benefit of $932,000 deferring the expenses associated with the PPP loan origination. The trend in the third quarter run rate of pre-tax pre-provision is primarily due to the timing of FAS 91 salary deferral in the second quarter that is not expected in future quarters. Our net interest margin held up well given the headwinds. We've enhanced our margin disclosure in our press release tables by adding granularity to the table in the loan section. NIM declined 2 basis points linked quarter, showing stability in total earning assets and cost of interest-bearing liabilities. We are particularly happy about the progress made in our interest-bearing deposits with the cost declining 13 basis points linked quarter. Late in the third quarter, we paid off a relatively higher cost FHLB borrowing that had a notional value of $250 million. We expect to see some modest improvement in the cost of FHLB advances in the fourth quarter, offset by a modest increase in cost of other borrowings as we only have 2 months of the $75 million subordinated debt in the third quarter. As Greg and I mentioned in the second quarter earnings call, the expectation for future declines in interest-bearing deposits will largely be driven by continued repricing of the CD portfolio. The average life of that portfolio is about 14 months and we are 9 months into the repricing. So we expect to see another quarter of benefit before we level out. On the interest-earning assets, we have taken a measured approach to new origination yields, generally originating loans with a 4 handle versus a 3 handle. This has allowed us to maintain relative stability in the yield earned on our loans, declining 6 basis points linked quarter. The total securities portfolio is expected to continue to decline in yield. And over time as we see loan demand, we will remix the composition of our earning assets into loans. If we exclude PPP loans from the NIM analysis, for the quarter ending September 30th, the yield on C&I, total loans and total earning assets would be 5.16%, 5.01% and 4.19%, respectively. This compares to 5.23%, 5.07%, and 4.24%, respectively, for the quarter ending June 30th. Excluding PPP loans again, pro forma NIM for the quarters ending September 30th and June 30th would be 3.59% and 3.65%, respectively. You will note that our provision for loan loss was $815,000, materially lower than what we recorded in the first half of 2020. As a reminder, we continue to be under the incurred loss methodology for the allowance for loan losses, and we used qualitative factors in the first half of 2020 to add $22.4 million to the allowance for loan losses. Qualitative factors included the rise in unemployment and the incidence of deferred loans. While these factors have both eased, the uncertainty remains. Facts and circumstances have not materially changed, which drove the minimal provision in the quarter. If circumstances remain unchanged, we do not believe a material provision under the incurred loss method will result in the fourth quarter. At September 30th, we had $5.7 million of credit marks on acquired loans. When included in the ALLL, the pro forma coverage ratio rises to 1.69% when excluding the ending balance of PPP loans from the denominator. Under the CARES Act, we're required to adopt CECL at December 31, 2020, and are ready to do so. When adopting CECL, the effect of the adoption will run through capital and not current period earnings. We are expecting that at December 31, after adopting CECL, our ACL coverage of non-PPP loans is expected to be north of 2%, positioning us well for 2021. Greg?